
Dianthus Therapeutics: Celebrating Recent Business Milestones and Announcing Q4 & FY 2024 Financial Results
Dianthus Therapeutics: Updates on Ongoing Clinical Trials and Financial Status Dianthus Therapeutics, a clinical-stage biotechnology company, recently reported their financial results for the fourth quarter and full year ending December 31, 2024. The company also provided an update on their recent business achievements. Let’s delve deeper into these updates. Clinical Trials In the world of…